uniQure Ownership | Who Owns uniQure?
uniQure Ownership Summary
uniQure is owned by 37.24% institutional investors, 8.29% insiders, and 54.47% retail investors. Vestal point capital, lp is the largest institutional shareholder, holding 9.02% of QURE shares. abrdn Healthcare Investors is the top mutual fund, with 2.59% of its assets in uniQure shares.
QURE Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | uniQure | 37.24% | 8.29% | 54.47% |
| Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
| Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vestal point capital, lp | 4.79M | 9.02% | $50.80M |
| Rtw investments, lp | 4.27M | 8.03% | $45.21M |
| Ecor1 capital | 3.40M | 6.98% | $60.04M |
| Nantahala capital management | 2.76M | 5.19% | $29.21M |
| Avoro capital advisors | 2.17M | 4.10% | $23.05M |
| Franklin resources | 1.99M | 4.08% | $35.10M |
| Blackrock | 1.93M | 3.98% | $8.63M |
| Point72 asset management | 1.77M | 3.64% | $31.28M |
| 683 capital management | 1.52M | 3.13% | $26.93M |
| Abrdn | 1.51M | 3.10% | $26.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vestal point capital, lp | 4.79M | 3.63% | $50.80M |
| Stempoint capital lp | 731.04K | 2.47% | $7.75M |
| Ecor1 capital | 3.40M | 2.27% | $60.04M |
| 683 capital management | 1.52M | 1.67% | $26.93M |
| Integral health asset management | 1.25M | 1.41% | $13.25M |
| Nantahala capital management | 2.76M | 1.16% | $29.21M |
| Birchview capital, lp | 88.70K | 0.82% | $940.19K |
| Rtw investments, lp | 4.27M | 0.69% | $45.21M |
| Privium fund management b.v. | 640.42K | 0.66% | $2.57M |
| Parkman healthcare partners | 275.00K | 0.65% | $4.86M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ecor1 capital | 3.40M | 2.27% | 3.40M |
| Rtw investments, lp | 4.27M | 0.69% | 3.36M |
| Vestal point capital, lp | 4.79M | 3.63% | 1.77M |
| Point72 asset management | 1.77M | 0.07% | 794.46K |
| Stempoint capital lp | 731.04K | 2.47% | 641.04K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Schroder investment management group | 834.08K | 0.01% | -634.57K |
| Ikarian capital | - | - | -469.13K |
| Hudson bay capital management lp | 175.00K | 0.01% | -460.50K |
| Alphacentric advisors | - | - | -460.00K |
| Avidity partners management lp | 222.00K | 0.39% | -451.62K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ecor1 capital | 3.40M | 2.27% | 3.40M | $60.04M |
| Sofinnova investments | 545.77K | 0.38% | 545.77K | $5.79M |
| Affinity asset advisors | 400.00K | 0.40% | 400.00K | $4.24M |
| Lord, abbett | 314.41K | 0.02% | 314.41K | $5.55M |
| Parkman healthcare partners | 275.00K | 0.65% | 275.00K | $4.86M |
Sold Out
| Holder | Change |
|---|---|
| Northwestern mutual wealth management | -1.00 |
| Gamma investing | -20.00 |
| Nelson, van denburg & campbell wealth management group | -32.00 |
| Pineridge advisors | -38.00 |
| Physician wealth advisors | -47.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 23 | -85.35% | 19,779,316 | -52.46% | 37 | 0.51% | 14 | -81.08% | 5 | -89.36% |
| Dec 31, 2024 | 148 | 4.23% | 38,592,241 | -0.74% | 79 | 1.24% | 68 | -2.86% | 45 | 21.62% |
| Sep 30, 2024 | 141 | 9.30% | 38,878,066 | 22.43% | 79 | 1.85% | 69 | 23.21% | 37 | - |
| Jun 30, 2024 | 129 | -6.52% | 31,756,298 | -1.57% | 65 | 1.44% | 56 | -22.22% | 37 | 15.63% |
| Mar 31, 2024 | 138 | -11.54% | 32,262,781 | -13.94% | 67 | 1.10% | 72 | - | 32 | -43.86% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| abrdn Healthcare Investors | 1.42M | 2.59% | 14.60K |
| Franklin Biotechnology Discv A(acc)USD | 1.04M | 1.89% | - |
| SPDR® S&P Biotech ETF | 839.85K | 1.53% | -13.72K |
| Vanguard Institutional Extnd Mkt Idx Tr | 796.17K | 1.45% | 5.75K |
| Delaware Healthcare I | 706.17K | 1.45% | - |
| Macquarie Healthcare I | 706.17K | 1.29% | - |
| International Biotechnology Ord | 693.28K | 1.27% | -170.97K |
| abrdn Life Sciences Investors | 654.74K | 1.20% | 6.26K |
| abrdn World Healthcare | 585.08K | 1.07% | 61.47K |
| Franklin Biotechnology Discovery A | 568.80K | 1.04% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 27, 2025 | Abi-Saab Walid | Chief Medical Officer | Sell | $20.41K |
| Jun 20, 2025 | Springhorn Jeremy P. | - | Sell | $30.52K |
| Jun 20, 2025 | POST LEONARD E | - | Sell | $30.52K |
| Jun 20, 2025 | Kaye Jack | - | Sell | $30.52K |
| Jun 20, 2025 | Jacques Rachelle Suzanne | - | Sell | $30.52K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 8 |
| 2024 Q4 | - | 3 |
| 2024 Q2 | - | 12 |
| 2024 Q1 | - | 3 |
QURE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools